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Abstract
Background: Cystic echinococcosis, caused by infection with Echinococcus granulosus, is one of the most widespread
zoonotic helminth diseases. Modulation of host responses is an important strategy used by helminth parasites to
promote infection. To better understand the mechanisms adopted by E. granulosus to escape host immune responses,
we investigated the effects of excretory–secretory products (ES) and adult worm antigen (AWA) derived from adult E.
granulosus on murine bone marrow-derived dendritic cells (BMDC).
Results: Compared with lipopolysaccharide (LPS), AWA, but not ES, induced BMDC maturation or stimulated BMDC
cytokine production and co-stimulatory molecule expression (CD40, CD80 and MHC class II). Furthermore, ES-treated
BMDCs pulsed with ovalbumin exhibited reduced co-stimulatory molecule expression in comparison with untreated
BMDC, even in the presence of the strong Th1 inducer, CpG. Moreover, we detected the effects of ES-treated DC on T
cell activation by an in vitro T cell priming assay. We observed that ES-treated BMDC co-cultured with DO11.10
transgenic CD4+ T cells induced the generation of CD4+CD25+Foxp3+ T cells. In addition, in contrast to AWA-treated
BMDCs, which had markedly induced IFN-γ secretion and reduced of IL-4 levels in co-cultured T cells, ES-treated
BMDCs did not modify their capacity to stimulate IFN-γ or IL-4 production by T cells.
Conclusions: We conclude that ES of adult E. granulosus inhibited DC function, impaired the development of Th1 cells
induced by CpG, and induced CD4+CD25+Foxp3+ regulatory T cells in an IL-10-independent manner.
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Background
Cystic echinococcosis is a zoonosis with a global distribu-
tion that is caused by the dog tapeworm, Echinococcus
granulosus [1], often resulting in chronic infection and the
unlimited growth of hydatid cysts in the liver and lung of
humans and domestic animals. E. granulosus has a
complex life cycle that involves two hosts. The definitive
hosts are primarily dogs, which harbor adult worms in
their small intestines. Humans and herbivores, particularly
sheep, are intermediate hosts of this parasite. Intermediate
hosts become infected by ingesting the eggs released in
the feces of definitive hosts. Dogs, as the definitive hosts,
are pivotal in the transmission of cystic echinococcosis.
Parasitic helminths are capable of maintaining infection
for long time periods despite the defense mechanisms of
the host. Consequently, these organisms have evolved a
wide range of highly elaborate survival strategies,
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including immunomodulation, antioxidant defenses and
resistance to host proteolytic enzymes [2, 3]. However,
most of the mechanisms that underlie the downregulation
of host responses remain largely unclear, especially at the
molecular level, although they are likely to be mediated by
proteins found in the parasite somatic extract and
excretory-secretory (ES) products (ES) [4, 5].
Dendritic cells (DC) are known to be essential im-
mune cells in innate immunity and in the initiation of
adaptive immunity [6, 7]. The shaping of adaptive im-
munity by innate immunity is dependent on the unique
cellular functions of DCs and DC-derived effector mole-
cules, such as cytokines and chemokines. At the inter-
face of the innate and adaptive immune systems, DC
senses the invading pathogen and initiates Th1 or Th2
immune responses. Accumulating evidence has demon-
strated that pathogens have evolved multiple strategies
to subvert the function of DCs. Previous studies have
established that the larval stages of Echinococcus spp.
modulate the function of DCs via ES products. The
hydatid cyst fluids and antigen B of E. granulosus have
been reported to modulate DC differentiation and cyto-
kine secretion [8, 9], and the laminated layer induces
the unconventional maturation of DCs [10]. In addition,
ES products of E. multilocularis larvae induce DC apop-
tosis and the generation of CD4+CD25+Foxp3+T cells
[11]. In our previous work, MHC-II, which is expressed
on the surface of antigen presenting cells (APCs), was
found to be downregulated during the early stage of E.
granulosus infection, which suggests a role for ES prod-
ucts in APC function [12]. Overall, the targeting and
impairment of DC function is an important immune es-
cape strategy employed by larval Echinococcus spp.;
however, whether adult ES products or adult worm anti-
gen (AWA) can influence the function of DC remains
unknown. The adult parasite stage causes no symptoms
in dogs, and this coexistence probably results from the
immunomodulation achieved by the adult worm. There-
fore, the effects of adult E. granulosus-derived products
on DC function are an interesting area for research.
In this study, we assessed the effects of treatment of
either E. granulosus ES or AWA on the maturation of
DC and CD4+ T cell activation in response to treated
DCs. The aim of this study was to assess the immuno-
modulatory function of adult somatic cell extracts,
which may play an important role in parasite–host
interactions. The in vitro exposure of bone marrow-
derived DC (BMDC) to AWA, but not ES, induced DC
maturation and treatment with ES impaired the ability
of DC to induce immune responses, even in the presence
CpG, a strong Th1 inducer. To the best of our knowledge,
this is the first report to shed light on the immunosup-
pressive effects of adult ES on DC maturation and subse-
quent T cell activation.
Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institute of Para-
sitic Diseases, Chinese Center for Disease Control and
Prevention. The protocol was approved by the Labora-
tory Animal Welfare & Ethics Committee (LAWEC),
National Institute of Parasitic Diseases, Chinese Center
for Diseases Control and Prevention (Permit Number:
IPD 2011-006). All surgery was performed under sodium
pentobarbital anesthesia, and all efforts were made to
minimize suffering.
Parasites and animals
Adult E. granulosus worms collected from dogs were
kindly provided by the Qinghai Institute for Endemic
Disease Prevention and Control. All experimental mice
were maintained under pathogen-free conditions. BALB/c
mice were obtained from the Shanghai Laboratory Animal
Center, Chinese Academy Sciences and DO11.10 αβ T cell
receptor transgenic mice (on a BALB/c background) were
purchased from the Model Animal Research Center of
Nanjing University.
Excretory–secretory product and adult worm antigen
preparation
Adult E. granulosus worms were collected from the intes-
tine by dissection microscopy, washed extensively with
sterile PBS (Gibco, California, USA) containing 100 U/ml
penicillin G, 100 μg/ml streptomycin (Gibco, California,
USA) and cultured at a density of approximately 500
worms per ml serum-free RPMI 1640 medium (Gibco,
California, USA) supplemented with 2 % glucose (Sigma-
Aldrich, Missouri, USA) and antibiotics for 24 h at 37 °C.
To generate ES, the supernatant was harvested,
centrifuged to remove eggs and worm debris and
concentrated using a micro-concentrator with a 5 kDa
cut-off (Millipore, Nassachusetts, USA). To prepare total
adult worm antigen, the remaining adult worms from
the culture were washed with PBS and homogenized by
sonication. The homogenate was centrifuged (10000 g,
5 min) and the soluble fraction collected as AWA. ES
and AWA were stored at −80 °C until used. A 2D Quant
Kit (Amersham Biosciences, Buckinghamshire, UK) was
used to determine the protein concentration in these
preparations. The test for endotoxins was performed in
AWA and ES, respectively. DCs showed the negligible
expression of co-stimulatory molecules after stimulation
with the same level of LPS, which suggested that the
presence of LPS in purified antigens was lower than its
effective concentration.
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Generation of BMDC
BMDC were obtained according to a method adapted
from Inaba et al. [13] and Lutz et al.[14]. Briefly, total
bone marrow cells were collected from the femur of
BALB/c mice and red blood cells were lysed using RBC
Lysis Buffer (Beyotime, Shanghai, China). After washing
with RPMI-10 (Hyclone, Utah, USA) three times, the
bone marrow cells were resuspended in RPMI-10 con-
taining 10 ng/ml granulocyte-macrophage colony
stimulating factor (GM-CSF; Peprotech, London, UK)
at 1 × 106 cells/ml and cultured for 7 days at 37 °C in a
humidified CO2 incubator. Cells were fed on days 3
and 5. On day 7, DC clusters were harvested and
subcultured overnight to remove adherent cells. Non-
adherent cells were collected on day 8 by gentle pipet-
ting and washed CD11c+ cells were then purified using
a Magnetic-activated Cell Sorting System (Miltenyi
Biotec, Auburn, CA) as immature BMDC for use in ex-
periments.
In vitro BMDC stimulation assays
BMDC were resuspended at 106 cells/ml in complete
medium containing 10 ng/ml GM-CSF and stimulated
with PBS (Gibco, California, USA), lipopolysaccharide
(LPS; 100 ng/ml; from E. coli strain 0111:B4; Sigma-
Aldrich, Missouri, USA), ES (50 μg/ml) or AWA
(50 μg/ml) for 24 h. Cells were harvested for flow cyto-
metric analysis of surface marker expression and super-
natants were collected for cytokine quantification using
an enzyme-linked immunosorbent assay.
Flow cytometric analysis
For cell surface staining, 106 cells were washed and
treated for 30 min on ice with Fc receptor-blocking
reagent (FcγIII/IIR Ab; BD PharMingen, California,
USA) in sorting buffer (PBS with 1 % fetal calf serum).
Blocked cells were then incubated with PE-labeled anti-
CD86 monoclonal antibody (mAb; clone GL-1), APC-
labeled anti-CD80 mAb (clone 16-10A1), PeCY5-labeled
anti-CD40 mAb (clone 3/23) and FITC-labeled anti-MHC
class II mAb (Aβb, clone AF6-120.1) purchased from BD
PharMingen. After washing, cells were resuspended in
sorting buffer for flow cytometric analysis using a FACS-
Calibur (BD Biosciences, New Jersey, USA). At least
10,000 gated events were acquired per sample and data
analysis was performed using CellQuest or FlowJo
software.
Fig. 1 ES from E. granulosus, but not AWA, failed to induce DC maturation in vitro. Expression of surface markers by BMDC stimulated with PBS,
LPS (100 ng/ml), ES (50 μg/ml) or AWA (50 μg/ml) for 24 h. Unstimulated BMDC served as an isotype control of the FC stain. MHC II, CD40, CD80
and CD86 histograms were obtained by gating cells based on positive CD11c staining. The percentage of CD11c+ cells expressing the marker is
indicated at the top of each histogram
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In vitro pulsing of BMDC with OVA
BMDC were resuspended at 106 cells/ml in complete
medium and treated with ES (50 μg/ml) for 2 h before
pulsing with 5 mg/ml OVA for 16 h at 37 °C in the
presence or absence of 1 μM CpG during the last 12 h.
After pulsing, cells were harvested for the flow cyto-
metric analysis of surface marker expression.
In vitro T cell priming assay
For determination of the T cell-polarizing function of
differentially activated BMDC, CD4+ T cells were
enriched from spleens of DO11.10 transgenic mice by
positive selection using anti-CD4 magnetic Beads
(Miltenyi Biotec, Auburn, CA) according to the in-
structions provided by the manufacturer. These cells
express a T cell receptor specific for an ovalbumin
(OVA) peptide (323-ISQAVHAAHAEINEAGR-339)
presented in the context of I-Ad MHC class II. Puri-
fied CD4+ T cells were washed three times and resus-
pended at 2 × 106 cells/ml in complete medium. BMDC
were resuspended at 4 × 105 cells/ml in complete medium
and were treated with ES (50 μg/ml), AWA (50 μg/ml)
and LPS (100 ng/ml). Untreated DC were used as a con-
trol. BMDC were extensively washed and seeded into 48-
well culture plates (250 μl/well) in complete medium con-
taining 50 nM OVA323-339 peptide (AnaSpec, California,
USA). CD4+ T cells were added (250 μl/well) to obtain a
final T cell/BMDC ratio of 5:1. Co-cultures were incu-
bated for 48 h at 37 °C before the medium was removed
and fresh complete medium containing 10 ng/ml mouse
rIL-2 (R&D Systems, Wisconsin, USA) was added.
Fig. 2 Cytokine production by BMDC stimulated with PBS (as a control), LPS (100 ng/ml), ES (50 μg/ml) or AWA (50 μg/ml) in vitro. BMDC were
cultured with the indicated stimuli and the production of IL-6, IL-10, TNF-α, IL-12p40 and IL-12p70 was determined by ELISA. Data are expressed
as mean pg/ml ± SE from three independent experiments. *P < 0.05 compared to cytokine production in control
Table 1 The phenotype of DC with different stimuli
N = 3 PBS LPS ES AWA
MHC II 78 ± 1.08 96 ± 6.29 77 ± 2.29 89 ± 2.17*
CD40 32 ± 2.03 82 ± 2.64 41 ± 1.65* 67 ± 1.69*
CD80 59 ± 1.35 93 ± 2.45 61 ± 2.67 75 ± 1.33*
CD86 47 ± 1.58 76 ± 2.27 60 ± 0.95* 72 ± 1.78*
*P < 0.05
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Following an additional incubation for 72 h at 37 °C, cells
were harvested, washed and resuspended at 1 × 106 cells/
ml. For cytokine analysis by ELISA, 200 μl of this cell sus-
pension were seeded into 96-well flat-bottomed culture
plates coated with 5 μg/ml anti-mouse-CD3 mAb (Perpro-
tech, London, UK) and incubated for 48 h at 37 °C prior
to harvesting supernatants. For flow cytometric analysis of
T cell phenotype, 500 μl of the cell suspension was seeded
into 48-well flat-bottomed plates coated with anti-mouse-
CD3, incubated for 12 h at 37 °C prior to addition of
monensin (2 μl GolgiStop; BD PharMingen, California,
USA) and incubated for a further 5 h. Cells were harvested
and stained as described above.
Cytokine quantification
Levels of IL-4, IL-10 and IFN-γ in culture supernatants
were determined using an ELISA kit (Biolegend, Califor-
nia, USA) according to the instructions provided by the
manufacturer.
Fig. 3 Phenotypic characterization of OVA-pulsed BMDCs. Co-stimulatory molecule expression by control DCs or ES-treated DCs following OVA
pulsing. Histograms were obtained by gating cells based on positive CD11c staining. The percentage of CD11c+ cells that expressed the markers
is indicated at the top of each histogram (the red line and the sky blue line refer to the isotype control and the positive stain, respectively)
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Statistical analysis
Statistical significance was evaluated by one-way ANOVA.
Values of P < 0.05 were considered to be statistically
significant.
Results
ES failed to induce DC maturation and robust cytokine
production
The ability of ES and AWA to induce DC maturation and
cytokine production was investigated by using LPS as a
positive control and PBS as a negative control. Expression
of co-stimulatory molecules (CD40, CD80, CD86 and
MHC class II) was analyzed by flow cytometry flowing in
vitro stimulation of CD11c+ BMDC with ES, AWA, LPS
or PBS alone. Interestingly, ES and AWA showed different
effects on DC maturation: DC stimulated with AWA
expressed higher levels of CD40, CD80, MHC class II and
CD86 compared with DC stimulated with PBS (Fig. 1, data
are shown in Table 1), manifesting a conventional mature
phenotype, similar to that obtained with LPS. In contrast, the
expression of co-stimulatory molecules on ES-treated
BMDCswas equivalent to that observed in PBS-treated cells.
Next, we detected the production of cytokines in
BMDCs in response to different stimuli. AWA treatment
induced the elevation of IL-6, IL-10, TNF-α, IL-12p40 and
IL-12p70 levels in BMDCs (Fig. 2) compared to PBS
(negative control), but these were lower than LPS-induced
cytokine production levels. In contrast, ES treatment only
induced marginal IL-6 and IL-10 production compared to
negative controls. Thus, AWA rather than ES induced DC
maturation and robust cytokine production.
ES impair TLR ligand-induced DC maturation in vitro
To evaluate the effects of ES on DC maturation induced
by the Toll-like receptor (TLR) ligand, BMDCs were
stimulated with CpG in the presence of ES. As shown in
Fig. 3 (data are shown in Table 2), BMDCs pulsed with
OVA alone expressed higher levels of CD40 compared
with the unpulsed control cells stimulated with PBS. The
addition of CpG as an adjuvant during the final 12 h of
the OVA pulsing procedure induced higher levels of
CD40, CD80, CD86 and MHC class II expression com-
pared with BMDCs pulsed with OVA alone. The ES treat-
ment of DC before they were pulsed with OVA and CpG
reduced the expression of the co-stimulatory molecule
compared with the responses induced by DCs pulsed with
OVA and CpG. These results indicated that ES suppressed
DC maturation induced by the TLR ligand.
Fig. 4 Cytokine production by DO11.10 CD4+ T cells cultured alone or
co-cultured with LPS-, ES- or AWA-pretreated BMDC in vitro. CD4+ T
cells were purified from the spleens of naïve DO11.10 mice and
co-cultured with LPS-, ES- or AWA-pretreated BMDC or untreated BMDC
(control) in the presence of 50 nM OVA peptide for 48 h. The final T
cell/BMDC ratio was 5:1. After incubation, T cells were reactivated with
plate-immobilized anti-mouse CD3 for 48 h. Supernatants were
collected for analysis of cytokine production by ELISA. ES–pretreated
BMDC failed to enhance cytokine production by CD4+ T cells in vitro,
while AWA–pretreated BMDC upregulated secretion of IFN-γ and
downregulated secretion of IL-4. Spleens from three individual mice
were pooled in these experiments. Data are expressed as mean pg/ml
± SE from three independent experiments. *P < 0.05 compared to
cytokine production in control BMDC-T cell co-cultures
Table 2 The phenotype of OVA-pulsed DCs
N = 3 Control DC + OVA DC + OVA + CpG ES-DC + OVA + CpG
MHC II 62 ± 3.57 67 ± 3.25 85 ± 3.56* 67 ± 2.35
CD40 5 ± 2.14 15 ± 3.67* 70 ± 2.30* 18 ± 3.42*
CD80 17 ± 3.21 24 ± 3.25 42 ± 4.53* 21 ± 3.13
CD86 12 ± 2.75 22 ± 5.73* 40 ± 4.18* 26 ± 2.37*
*P < 0.05
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ES induced CD4+CD25+ Foxp3+ T cell generation
The effects of ES and AWA on the ability of BMDC to
stimulate CD4+ T cell cytokine production was also exam-
ined using naïve CD4+ T cells purified from the spleens of
DO11.10 OVA-specific T cell receptor transgenic mice.
Preliminary studies demonstrated that stimulation of
DO11.10 CD4+ T cells co-cultured with control BMDC
and 50 nM OVA peptide induced high levels of expression
of both IFN-γ and IL-4, and a modest level of IL-10. DCs
alone or T cells co-cultured with BMDCs in the absence of
OVA peptide produced negligible amounts of these cyto-
kines (data not shown). As shown in Fig. 4, co-culture with
LPS-pretreated BMDCs led to a significant increase in the
production of IFN-γ and IL-10, and a reduction of IL-4
production in CD4+ T cells. Similarly, AWA-pretreated
BMDC stimulated CD4+ T cells to secrete higher levels of
IFN-γ compared with the control. In contrast, the ES pre-
treatment of BMDCs with ES did not modify their capacity
to stimulate IFN-γ or IL-4 production by T cells.
Surface expression of CD4 and CD25 and intracellular ex-
pression of Foxp3 were also analyzed. ES-pretreated BMDC
induced an increase in the percentage of CD4+Tcells express-
ing CD25 and Foxp3 (Fig. 5, data are shown in Table 3). These
data suggest that BMDC exposed to ES induced a regulatory
population of CD4+ Tcells that express these twomarkers.
Table 3 The percentage of CD25+Foxp3+ cells in DC-T cell
co-cultures
N = 3 DC + OVA ES-DC + OVA
CD25+Foxp3+ 4 ± 1.76 11 ± 2.17*
*P < 0.05
Fig. 5 ES induced CD4+CD25+ Foxp3+ T cell generation. BMDC–T cell co-culture was performed as described above in the presence of 50 nM OVA.
After initial incubation, T cells were reactivated with plate-immobilized anti-mouse CD3 for 12 h, harvested and analyzed by combined surface and
intracellular FACS staining. T cells were gated on the basis of CD4+ staining and analyzed for surface CD25 staining and intracellular Foxp3 staining.
The percentage of CD4+CD25+Foxp3+ T cells is indicated in the upper right quadrant
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Discussion
In this study, the inability of adult E. granulosus ES to
induce DC maturation and cytokine production was
demonstrated in vitro for the first time. ES was shown
to suppress DC maturation. AWA was shown to induce
a conventional maturation of DC, contrary to the effects
of ES. A previous proteomic analysis of the pre-adult
stage of E. granulosus demonstrated that there are differ-
ent components and abundance of protein(s)/antigen(s)
of parasite during different stages, different hosts, and
even during the same stage [15–18]. Although ES and
AWA are derived from the same stage of E. granulosus,
the constituents and abundance of specific protein(s)/an-
tigen(s) are most likely to be distinct. It has been pro-
posed that different types of antigen(s) in ES and AWA
may be responsible for differences between the effects of
ES and AWA, and especially those antigens that are
more abundant. In our preliminary proteomic analysis of
the ES and AWA, we observed that the abundance of
some proteins are significantly more in the ES, which
supported this hypothesis. Some immunomodulatory
components and other molecules of Echinococcus have
been identified, including AgB, elongation factor EgEF-
1β/δ, EA21, EgHSP70, EgTeg of E. granulosus, and Em2
and Em492 of Echinococcus multilocularis [19–28]. In
our preliminary research, we identified novel proteins
within the ES of adult E. granulosus using a two-
dimensional electrophoresis, tandem matrix-assisted
laser desorption/ionization time-of-flight (MALDI-TOF/
TOF) method (data not published). However, the exact
nature of the immunomodulatory component(s) in adult
E. granulosus-derived ES and the associated receptor(s)
remain to be elucidated.
Many helminth-derived proteins, glycoconjugates and
small lipid moieties have been identified that are thought
to contribute to the immunosuppression associated with
parasites [29–31]. Our finding of an immature pheno-
type and weak cytokine production in DCs stimulated
with ES is consistent with previous reports of the inabil-
ity of other helminth products, such as the filarial glyco-
protein ES-62 and schistosome-derived soluble egg
antigen, to induce DC maturation [32, 33]. In contrast,
DC exposed to Nippostrongylus brasiliensis ES display
increased CD40 and CD86 expression and production of
IL-6 and IL-12p40 [29]. These data indicate that some
helminth products induce an immature DC phenotype
while others induce selective maturation of DC associ-
ated with Th2 polarization.
DC recognition of TLR ligands is the first line of defense
against pathogens and contributes to activation of adaptive
immune responses. The CpG motif induces a highly polar-
ized Th1 response and is generally recognized by TLR9,
which is expressed by DC. Therefore, we investigated the
capacity of ES to modulate CpG-induced DC activation. In
accordance with previous results, CpG induced the expres-
sion of CD40, CD80, CD86 and MHC class II, whereas ES
suppressed CpG-mediated induction of all these markers,
thus demonstrating a strong inhibitory effect on CpG-
induced DC maturation. Together, our data suggest that
ES have a broadly suppressive effect on DC activation and
on the cytokine network that regulates the magnitude of
Th1 responses. Thus, we speculate that inhibition of DC
maturation and function represents a potential immuno-
suppressive mechanism used by E. granulosus, in a similar
way to Heligmosomoides polygyrus, Schistosoma japonicum
and other pathogens [34–36], although further experi-
ments are required to confirm this hypothesis.
Regulatory T cells (Tregs) play an important role in im-
munosuppression and have the capacity to inhibit innate
and adaptive immunity, including both Th1 and Th2 re-
sponses [37–39]. We observed in this study that ES-
treated DC co-cultured with DO11.10 transgenic CD4+ T
cells induced the generation of CD4+CD25+Foxp3+ T cells
with no increase in IL-4, IL-10 and IFN-γ secretion com-
pared with controls. The phenotype of the CD4+ T cell
population described here differs from that identified by
Vieira et al. [40] and Segura et al. [41], consisting of CD4
+CD25+ T cells that secrete IL-10 and do not express
Foxp3, but have regulatory function comparable with that
of naturally occurring Tregs. Nevertheless, Vieira et al.
demonstrated that, despite lack of Foxp3 expression, IL-
10-secreting Tregs were found to produce little IL-2,
express high levels of CD25 and inhibit effector T cell pro-
liferation in vitro in an IL-10-independent manner [40, 42,
43]. Segura et al. described a similar effect mediated by an
IL-10-dependent mechanism [41]. The lack of IL-10 pro-
duction in the cells identified in this study suggests that
the inhibitory effect of CD4+CD25+Foxp3+ Tregs occurs
via an IL-10-independent mechanism.
Conclusions
In this study, our data provide evidence that ES secreted
by adult E. granulosus exerts a potent inhibitory effect on
the maturation and function of DC, which in turn may
drive the differentiation of CD4+ T cells into Tregs and
suppress cytokine production in a generalized manner ir-
respective of their Th1 or Th2 phenotypic affiliation. In
addition to increasing knowledge of E. granulosus infec-
tion, our study provide further understanding of the cellu-
lar and molecular mechanisms involved in the modulation
of host immune responses by helminths and pave the way
for the development of anti-helminthic treatment and dis-
ease control strategies.
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